Evidence map›Paper›PMID 40893800›Full record

ArticleIJID regions2025

Insights into the phylogenetic profile and virulence-associated genes of multidrug-resistant uropathogenic

Raheleh Sheikhi, Sara Darvishvand, Mohammad Shenagari, Ali Monfared, Masoud Khosravi, Mojgan Sigarchi, Elham Ramezanzade, Mohammad-Kazem Lebadi, Yalda Haghdar-Saheli, Pegah Aghajanzadeh and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in IJID regions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Raheleh SheikhiDepartment of Microbiology, Virology and Microbial Toxins, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
Sara DarvishvandDepartment of Microbiology, Virology and Microbial Toxins, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
Mohammad ShenagariDepartment of Microbiology, Virology and Microbial Toxins, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
Ali MonfaredUrology Research Center, School of Medicine, Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran.
Masoud KhosraviUrology Research Center, School of Medicine, Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran.
Mojgan SigarchiDepartment of Microbiology, Virology and Microbial Toxins, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
Elham RamezanzadeUrology Research Center, School of Medicine, Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran.
Mohammad-Kazem LebadiUrology Research Center, School of Medicine, Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran.
Yalda Haghdar-SaheliUrology Research Center, School of Medicine, Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran.
Pegah AghajanzadehUrology Research Center, School of Medicine, Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran.
Ali MovassaghiUrology Research Center, School of Medicine, Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Urinary tract infections caused by multidrug-resistant uropathogenic Methods: UPEC isolates were subjected to phylogenetic and virulence genotyping using conventional and multiplex polymerase chain reaction methods. Antimicrobial susceptibility patterns were determined using disk diffusion method. Results: Among 105 UPEC isolates, phylogenetic group B2 was the most prevalent (42.7%), followed by unknown (21.3%), E (15.7%), B1 (13.5%), and D (6.7%) among MDR UPEC isolates. A high prevalence of virulence genes, including Conclusions: The findings support the potential of these genes as targets for vaccine development and highlight the necessity for continued regional research to address antibiotic resistance and improve urinary tract infection management in order to select appropriate treatments.

Indexed as

Multi-drug resistantPhylogeneticUrinary tract infectionUropathogenic Escherichia coliVirulence genes

Identifiers

PMID40893800
PMCPMC12390940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.